Devin W. Steenkamp, MBChB
Assistant Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Endocrinology, Diabetes, Nutrition & Weight Management

MBChB, University of Pretoria



Devin Steenkamp is an endocrinologist with a particular interest in type 1 diabetes and atypical diabetes phenotypes such as monogenic diabetes. He is the Director of the Clinical Diabetes Program in the Section of Endocrinology, Diabetes and Nutrition at Boston Medical Center/Chobanian and Avedisian School of Medicine and his clinical practice and research interests are focused on the application of diabetes technologies in care

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research





Continuous glucose monitoring in a community study: determinants and prediction of diabetes mellitus development in the Framinghm Heart Study.
04/01/2022 - 03/31/2027 (Subcontract PI)
PI: Devin W. Steenkamp, MBChB
Trustees of Boston University, BUMC NIH NIDDK
1R01DK129305-01

INHALE-3 A 17-Week Randomized Trial and a 13-Week Extension, Evaluating the Efficacy and Safety of Afrezza Combined with Degludec (Tresiba) Versus Usual Care in Adults with Type 1 Diabetes
06/21/2023 - 06/20/2026 (PI)
JAEB Center For Health Research, Inc.

TP-0013437 A Randomized Trial Evaluating the Efficacy and Safety of Control-IQ Technology in Adults with Type 2 Diabetes Using Basal-Bolus Insulin Therapy (2IQP)
06/01/2023 - 05/31/2026 (PI)
JAEB Center For Health Research, Inc.

FOCUS - Long-term effects of semaglutide on diabetic retinopathy in subjects with type 2 diabetes
07/01/2019 - 07/31/2025 (PI)
Novo Nordisk

Quality Improvement (Q1) Program
04/28/2021 - 06/30/2025 (PI)
T1D Exchange, Inc.

ADC-US-RES-19185: Evaluation of Flash Continuous Glucose Monitoring to Reduce Hyperglycemia in People with T2 Diabetes
05/11/2022 - 05/10/2025 (PI)
Abbott Laboratories

REDUCING INEQUITIES IN DIABETES TECHNOLOGY
02/01/2023 - 03/31/2024 (PI)
T1D Exchange, Inc.

F3Z-MC-IORN Meal-centric Insulin Dosing for Optimized Post-Prandial Glucose Control in People Using Multiple Daily Injections
06/04/2021 - 05/01/2023 (PI)
Lilly USA, LLC

Glycemla Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
08/01/2014 - 01/28/2023 (PI)
Mass General Hosp NIH-NIDDK

SWITCH Pro: A randomised, cross-over, open-label, multi-centre trial comparing the effect of…
09/23/2018 - 08/25/2021 (PI)
Novo Nordisk

Showing 10 of 16 results. Show All Results

Title


Yr Title Project-Sub Proj Pubs

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Spartano NL, Sultana N, Lin H, Cheng H, Lu S, Fei D, Murabito JM, Walker ME, Wolpert HA, Steenkamp DW. Defining continuous glucose monitor time in range in a large community-based cohort without diabetes. J Clin Endocrinol Metab. 2024 Sep 11.View Related Profiles. PMID: 39257191; DOI: 10.1210/clinem/dgae626;
     
  2. Hirsch IB, Beck RW, Marak MC, Calhoun P, Mottalib A, Salhin A, Manessis A, Coviello AD, Bhargava A, Thorsell A, Atakov Castillo A, Bode BW, Levister C, Levy CJ, Donahue C, Cordero C, Beatson C, Langel CR, Jacobson C, Kurek C, Cruse D, Pickering D, Tamarez D, Steenkamp DW, Desjardins D, Aleppo G, O'Malley G, Akturk HK, Diner J, Baran JD, Buse JB, Ruedy K, Codorniz K, Klein KR, Castorino K, Jordan LF, Kipnes M, Church MM, Hamdy O, Raskin P, Nguyen QT, Weinstock RS, Lee S, Rizvi S, Bzdick S, Ghorbani Rodriguez T, Salah T, Blevins T, Kudva YC, Haider Z. A Randomized Comparison of Postprandial Glucose Excursion Using Inhaled Insulin Versus Rapid-Acting Analog Insulin in Adults With Type 1 Diabetes Using Multiple Daily Injections of Insulin or Automated Insulin Delivery. Diabetes Care. 2024 Sep 01; 47(9):1682-1687. PMID: 39042575; PMCID: PMC11362108; DOI: 10.2337/dc24-0838;
     
  3. Steenkamp D, Brouillard E, Aia C, Fantasia K, Sullivan C, Atakov-Castillo A, Wolpert H. Reducing Inequity in the Use of Automated Insulin Delivery Systems by Adults With Type 1 Diabetes: Key Learnings From a Safety Net Diabetes Clinic Program. Endocr Pract. 2024 Jun; 30(6):558-563.View Related Profiles. PMID: 38583773; DOI: 10.1016/j.eprac.2024.04.001;
     
  4. Steenkamp DW, Fantasia KL, Wolpert HA. Optimizing Glycemic Outcomes for Minoritized and Medically Underserved Adults Living with Type 1 Diabetes. Endocrinol Metab Clin North Am. 2024 Mar; 53(1):67-80.View Related Profiles. PMID: 38272599; DOI: 10.1016/j.ecl.2023.07.001;
     
  5. Ferkowicz MJ, Verma A, Barwinska D, Melo Ferreira R, Henderson JM, Kirkpatrick M, Silva PS, Steenkamp DW, Phillips CL, Waikar SS, Sutton TA. Molecular Signatures of Glomerular Neovascularization in a Patient with Diabetic Kidney Disease. Clin J Am Soc Nephrol. 2024 Feb 01; 19(2):266-275.View Related Profiles. PMID: 37533147; PMCID: PMC10861111; DOI: 10.2215/CJN.0000000000000276;
     
  6. Steenkamp DW, Cheney MC, Ju Z, Rodbard D, Wolpert HA. Proof-of-concept Application of Continuous Glucose Monitoring Data Analytics to Identify Diabetes Glucotypes. J Endocr Soc. 2023 Mar 06; 7(5):bvad038.View Related Profiles. PMID: 37035501; PMCID: PMC10074392; DOI: 10.1210/jendso/bvad038;
     
  7. Williams ME, Steenkamp D, Wolpert H. Making sense of glucose sensors in end-stage kidney disease: A review. Front Clin Diabetes Healthc. 2022; 3:1025328.View Related Profiles. PMID: 36992784; PMCID: PMC10012164; DOI: 10.3389/fcdhc.2022.1025328;
     
  8. Steenkamp DW, Piarulli A, Middelbeek RJW, Wolpert HA. Severe hypoglycaemia while using a hybrid closed-loop insulin pump system: A reminder of the continued importance of patient education for pre-emptive hypoglycaemia mitigation. Diabet Med. 2023 Mar; 40(3):e14975.View Related Profiles. PMID: 36251520; DOI: 10.1111/dme.14975;
     
  9. Marks BE, Mungmode A, Neyman A, Levin L, Rioles N, Eng D, Lee JM, Basina M, Hawah-Jones N, Mann E, O'Malley G, Wilkes M, Steenkamp D, Aleppo G, Accacha S, Ebekozien O. Baseline Quality Improvement Capacity of 33 Endocrinology Centers Participating in the T1D Exchange Quality Improvement Collaborative. Clin Diabetes. 2022; 41(1):35-44. PMID: 36714248; PMCID: PMC9845085; DOI: 10.2337/cd22-0071;
     
  10. Ebekozien O, Mungmode A, Buckingham D, Greenfield M, Talib R, Steenkamp D, Haw JS, Odugbesan O, Harris M, Mathias P, Dickinson JK, Agarwal S. Achieving Equity in Diabetes Research: Borrowing From the Field of Quality Improvement Using a Practical Framework and Improvement Tools. Diabetes Spectr. 2022; 35(3):304-312. PMID: 36072814; PMCID: PMC9396719; DOI: 10.2337/dsi22-0002;
     
Showing 10 of 52 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 52 publications over 13 distinct years, with a maximum of 9 publications in 2017

YearPublications
20111
20134
20145
20152
20164
20179
20182
20196
20202
20215
20226
20233
20243

In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Type 1 Diabetes Mellitus
Proinsulin C Peptide
MODY

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
Contact for Mentoring:

75 E. Newton St
Boston MA 02118
Google Map

Download vCard

Steenkamp's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
See all (167) concept(s)
_
Co-Authors
See all (40) people
_
Similar People
See all (60) people
_
Same Department
Search Department